Prevention of Venous Thromboembolic Complications in Orthopaedic Surgery: New Possibilities


The causes of significant rate of venous thromboembolic complications after orthopaedic operations were analyzed basing on literature review and author's experience. Importance of orthopaedic surgeons' education in modern standard for such complication prevention as well as necessity of modern drugs application was presented. Data on the efficacy of new direct per oral anticoagulant Dabigatran etexilate (Pradax) were given.

About the authors

S S Kopyonkin



  1. Ахтямов И.Ф., Гарифуллов Г.Г., Миронова И.В. и др. Изменение свертывающей системы крови при эндо-протезировании тазобедренного сустава //Травматол. ортопед. России. - 2006. - N 4. - С. 38-42.
  2. Копенкин С.С., Бут-Гусаим А.Б., Скороглядов А.В. и др. Система профилактики венозных тромбоэмболических осложнений в травматолого-ортопедических отделениях стационаров //Вестн. РУДН. - 2008. - N 6. - С. 141-150.
  3. Копенкин С.С., Скороглядов А.В. Проблемы профилактики венозных тромбоэмболических осложнений при эндопротезировании крупных суставов //Вестн. травматол. ортопед. - 2009. - N 3. - С. 69-73.
  4. Сергеев К.С., Катренко И.Н., Торопов Е.В. и др. Ошибки, осложнения и меры их профилактики при эндо-протезировании тазобедренного сустава //Биомед. журн. - 2005. - Т. 6. - С. 219-220.
  5. Скороглядов А.В., Копенкин С.С. Тактика профилактики венозных тромбоэмболических осложнений в травматологии и ортопедии //Трудный пациент. - 2004. - N 10. - С. 8-14.
  6. Cohen A.T. et al. Venous thromboembolism risk and pro-phylaxis in the acute hospital care (ENDORSE study): multinational cross-sectional study //Lancet. - 2008. - N 371. - P. 387-394.
  7. Eriksson B., Dahl O., Buller H. et al. A new oral direct throm- bin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial //J. Thromb. Haemost. - 2005. - N 3. - P. 103-111.
  8. Eriksson B., Dahl O., Rosencher N. et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomized, double-blind, non-inferiority trial //Lancet. - 2007. - N 370. - P. 949-956.
  9. Eriksson B., Dahl O., Rosencher N. et al. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial //J. Thromb. Haemost. - 2007. - N 5. - P. 2178-2185.
  10. Geerts W., Pineo G., Heit J. et al. Prevention of venous thromboembolism //Chest. - 2008. - N 133. - P. 381-453.
  11. Rosencher N., Barre J., Osman M., Samama M. Prevention thromboembolique en chirurgie orthopedique prothetique du member inferieur//Maitrise Orthop. - 2002. - N 117. - P. 24-28.



Abstract - 18


Article Metrics

Metrics Loading ...


  • There are currently no refbacks.

Copyright (c) 2009 Kopyonkin S.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies